Nonpartisan civic infrastructure
AllCiv·Legis1
·

H.R. 7253

BillFederalHouseIn Committee
To amend the Federal Food, Drug, and Cosmetic Act to provide for clarification of requirements for the remanufacturing of medical devices, and for other purposes.
About This Bill
Committee
Latest Action · March 29, 2022
Referred to the Subcommittee on Health.
Congress
117th (2021–2023)
Introduced
March 28, 2022
Cosponsors (3)
2D 1R
View PDF ↗

Summary

Highlight any text to annotate
Clarifying Remanufacturing to Protect Patient Safety Act of 2022 This bill specifies that entities that remanufacture medical devices in a manner that could change the performance or safety specifications or the intended use of the device must register with the Food and Drug Administration as producers of medical devices and comply with related requirements.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.